Abstract: Cosmetic agents including a combination of at least two different active ingredients are provided herein. In one example, a cosmetic agent includes 2-butyloctanoic acid and at least one polyglyceryl-3 ester of a fatty acid in a cosmetically acceptable carrier.
Abstract: A solution including an antimicrobial polymer in a polar solvent and a method of producing the solution. The polymer has the structure of Formula (I). The antimicrobial solution may be coated onto a substrate and cured to provide an antimicrobial substrate in which the polymer is covalently bonded to the substrate so that it cannot leach from the substrate.
Abstract: The present invention provides for method of improving flowability and loose bulk density of functionalized natural- and/or synthetic calcium carbonate comprising material, to the use of such improved material in ready to use granules and thereof produced dispersible dosage forms.
Type:
Grant
Filed:
March 15, 2016
Date of Patent:
April 14, 2020
Assignee:
Omya International AG
Inventors:
Leonie Wagner-Hattler, Maxim Puchkov, Jörg Huwyler, Tanja Stirnimann, Carolina Diaz Quijano, Joachim Schoelkopf, Patrick A. C. Gane, Daniel E. Gerard
Abstract: The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na-CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.
Type:
Grant
Filed:
November 21, 2017
Date of Patent:
April 7, 2020
Assignee:
ATRIUM MEDICAL CORPORATION
Inventors:
Keith M. Faucher, Suzanne Conroy, Theresa K. Albergo, Joseph Bienkiewicz
Abstract: The present invention relates to extracts derived from plants and/or fractions thereof, compositions comprising same and use thereof in protecting tissues from damages caused by exogenous toxins. In particular, the present invention relates to polar extract and/or fraction thereof derived from Asteriscus graveolens, compositions comprising same and use thereof in protecting tissues comprising epithelial cell from the deleterious effect of exogenous toxins, particularly toxins originating from environmental pollution.
Type:
Grant
Filed:
February 1, 2016
Date of Patent:
March 3, 2020
Assignee:
I.B.R. Israeli Biotechnology Research Ltd.
Inventors:
Ofir Ramot, Fabien Havas, Eyal Kalo, Liki Von Oppen-Bezalel, Raffi Arnon, Olga Ben-Chitrit, Inon Perry
Abstract: The subject matter of the present invention is pertinent to the field of vaginal delivery of pharmaceutically active agents. Embodiments of the instant invention disclose methods for treating a variety of progesterone related disorders by vaginal administration of a pullulan capsule and a fill formulation comprising one or more antiprogestins dispersed in a mixture of isopropyl palmitate or isopropyl myristate and a polyethylene glycol.
Type:
Grant
Filed:
July 20, 2018
Date of Patent:
February 11, 2020
Assignee:
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Abstract: The present invention relates to a tablet comprising Afatinib or a pharmaceutically acceptable salt thereof, wherein the tablet is obtained by direct compression. The present invention further relates to a process for manufacturing a tablet of the invention as well as the use of the tablet of the invention.
Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s?1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s?1, as measured.
Abstract: The present invention relates to inhalation formulations of drugs in the form of dry powder for inhalation administration deliverable as such with an inhaler and provided with high deliverability, respirability and stability. In particular, the invention relates to a pharmaceutical composition for inhalation use in powder form comprising a first powder comprising at least a powder (a1) comprising an active agent or a pharmaceutically acceptable salt thereof, in an amount greater than 1% by weight of the powder, leucine in an amount from 5 to 70% by weight of said powder, a sugar in an amount from 20 to 90% by weight of the powder; and a second powder comprising a mixture of a first lactose which has an X50 from 35 to 75 ?m, with a second lactose which has an X50 from 1.5 to 10 ?m, the content of the first and second lactose in the mixture are respectively from 85% to 96% and from 4% to 15%.
Type:
Grant
Filed:
October 7, 2015
Date of Patent:
December 31, 2019
Assignee:
ZAMBON S.P.A.
Inventors:
Loretta Maggi, Giovanni Caponetti, Heike Butti, Cristina Veneziani, Laura Zanellotti
Abstract: A sterilization method is provided which acquires microbicidal activity equivalent to plasma-treated solution or more powerful than the same without the use of a plasma generation device. The sterilization method includes applying liquid containing peroxynitric acid (HOONO2) produced by chemical reaction to an object to be sterilized under acidic conditions of a pH value of 4.8 or lower. The liquid containing the peroxynitric acid is produced by mixing nitrous acid and peroxide together, for example, mixing nitrite and peroxide together.
Abstract: The present invention provides: a cosmetic composition carrier comprising an integrated sponge having a layered structure; and a cosmetic product comprising the same. According to the present invention, the cosmetic composition carrier facilitates the filling of a cosmetic composition, can uniformly carry the cosmetic composition for a long time, discharges an appropriate amount of the cosmetic composition when using the cosmetic composition, and can maintain excellent durability for a long time even after the cosmetic composition is carried.
Abstract: A bioenvironment-sensitive nanoparticle including a polymer having complementary charges, a method of manufacturing the same, and a pharmaceutical use of the bioenvironment-sensitive nanoparticle are disclosed. The bioenvironment-sensitive nanoparticle can be useful in stably and effectively delivering a target material such as a drug even when used at a small quantity since the nanoparticle is stable in extracellular environments. Also, the bioenvironment-sensitive nanoparticle can be useful in selectively diagnosing or treating cancer cells since the nanoparticle is specific to environments of the cancer cells.
Type:
Grant
Filed:
February 24, 2015
Date of Patent:
November 26, 2019
Assignee:
University-Industry Foundation, Yonsei University
Inventors:
Seungjoo Haam, Yong-min Huh, Hyun-Ouk Kim, Jihye Choi, Eunji Jang, Byunghoon Kang, Ilkoo Noh, Seungmin Han, Seung Won Song, Hwunjae Lee, Haejin Chun
Abstract: The disclosure relates to compounds and compositions for bone formation, fracture treatment, bone grafting, bone fusion, cartilage maintenance and repair, and methods related thereto. In certain embodiments, the disclosure relates to compositions comprising one or more compound(s) disclosed herein derivatives, or salt thereof, for use in bone growth processes. In a typical embodiment, a bone graft composition is implanted in a subject at a site of desired bone growth or enhancement. In certain embodiments, compounds disclosed herein are useful for managing obesity and diabetes or other metabolic syndromes by modulation of brown fat.
Abstract: The present invention relates to a drug delivery system comprising a core and a shell in which the core comprises a hydrolytically degradable polymer X which polymer backbone comprises pendant ester and acid functionalities and in which the shell comprises a hydrolytic degradable polymer Y. The hydrolytic degradable polymers X and Y are different polymers. Polymer X further comprises amino-acids in the polymer backbone and degrades via zero order degradation kinetics for a period of at least 3 months. Polymer Y degrades via auto-acceleration degradation kinetics.
Type:
Grant
Filed:
December 18, 2015
Date of Patent:
October 8, 2019
Assignee:
DSM IP ASSETS, B.V.
Inventors:
George Mihov, Guy Draaisma, Silvana Rensina Antonnietta Di Silvestre, Tristan Handels
Abstract: The invention provides methods of immobilizing an active agent to a substrate surface, including the steps of, providing a substrate, contacting the substrate with a solution of a compound including a trihydroxyphenyl group, thereby forming a trihydroxyphenyl-treated substrate, and contacting the trihydroxyphenyl-treated substrate with an active agent, thereby immobilizing the active agent on the substrate. Further provided are methods of immobilizing an active agent on a substrate, including the steps of providing a substrate, combining a solution of a compound including a trihydroxyphenyl group with a solution of an active agent, thereby forming a solution of an active agent-trihydroxyphenyl conjugate, and contacting the substrate with the solution of the active agent-trihydroxyphenyl conjugate, thereby immobilizing the active agent on the substrate. The invention further provides substrates and medical device or device components with active agents immobilized on the surface thereof.
Type:
Grant
Filed:
April 18, 2017
Date of Patent:
October 1, 2019
Assignees:
Baxter International Inc., Baxter Healthcare SA, Northwestern University
Inventors:
Ton That Hai, John-Bruce Devault Green, Timothy Michael Fulghum, Phillip Byron Messersmith, Tadas Stanislovas Sileika
Abstract: A UV/LED radiation-curable nail gel polish composition, method and the use thereof. The composition is comprised of oligomers and monomers and specially obtaining alcohol soluble thermoplastic resins. The advantage of this method is making the removing of the polymerized nail gel polish by medical alcohol easier and safer.
Abstract: A self-healing polymeric material includes a polymeric matrix material, a plurality of monomer mixture microcapsules dispersed in the polymeric matrix material, and a plurality of light generating microcapsules dispersed in the polymeric matrix material. Each monomer mixture microcapsule encapsulates a mixture of materials that includes monomers and a photoinitiator. Each light generating microcapsule encapsulates multiple reactants that undergo a chemiluminescent reaction. The chemiluminescent reaction generates a photon having a wavelength within a particular emission range that is consistent with an absorption range of the photoinitiator.
Type:
Grant
Filed:
June 23, 2017
Date of Patent:
August 27, 2019
Assignee:
International Business Machines Corporation
Inventors:
Eric J. Campbell, Sarah K. Czaplewski, Joseph Kuczynski, Timothy J. Tofil
Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.